KEBBI GOVT DONATES 10 HILUX VEHICLES TO BOOST SECURITY ON SOKOTO–BADAGRY SUPER HIGHWAY. (PHOTOS).
President Donald Trump on Monday called for pharmaceutical companies to “justify the success” of COVID-19 vaccines, despite previously praising the vaccines developed under his administration’s Operation Warp Speed program in 2020. Trump posted on Truth Social that while many see the vaccines as lifesaving miracles, others disagree, and he demanded more transparency from companies like Pfizer about the results of their studies.
The announcement comes amid ongoing federal changes to COVID-19 vaccine guidance. The Food and Drug Administration recently limited eligibility for the shots to adults 65 and older and those at higher risk of severe illness. Meanwhile, several top officials at the Centers for Disease Control and Prevention have resigned or been removed following disagreements with Health and Human Services Director Robert F. Kennedy over vaccine policy. Despite the shifts, CDC guidance continues to recommend COVID-19 vaccination for everyone six months and older, including pregnant and breastfeeding individuals, citing extensive studies showing safety and effectiveness. Trump highlighted his administration’s role in rapidly developing the vaccines and reiterated that the public deserves full disclosure about the data behind them.
Hospitalization and mortality data continue to show significant protection from COVID-19 vaccines. Studies indicate unvaccinated adults faced more than ten times the hospitalization risk and over twice the risk of death compared with vaccinated individuals during the Omicron surge. The vaccines, first authorized for emergency use in December 2020, have been credited with saving millions of lives in the U.S. The Pfizer-BioNTech, Moderna, and Johnson & Johnson vaccines were all subsidized by the federal government, allowing widespread access at no cost.
Trump, who received his first COVID-19 shot in January 2021, has consistently promoted vaccination while opposing mandates. His remarks arrive amid broader scrutiny of federal vaccine policy, including criticism of Kennedy’s decisions at HHS, such as rescinding grants for mRNA research and ending CDC extended protections. Former and acting CDC directors have expressed concern that recent actions could undermine public health security. The pharmaceutical companies have not yet responded to Trump’s call for further justification of the vaccines’ success.
Comments
Post a Comment